Scientific Article | Special Issue9. Ahayon MM. Specific characteristics of thepa<strong>in</strong>/depression association <strong>in</strong> the generalpopulation. J Cl<strong>in</strong> Psychiatry. 2004;65Suppl 12;5-9.10. Aquera L, Failde J, Cervilla JA, et al.<strong>Medical</strong>ly unexpla<strong>in</strong>ed pa<strong>in</strong> compla<strong>in</strong>ts areassociated with underly<strong>in</strong>g unrecognizedmood disorders <strong>in</strong> primary care. BMC FamPract. 2010;11:17. http://www.biomedcentral.com/1471-2296/11/17 [epubahead of pr<strong>in</strong>t]11. Paulozzi LJ, Ryan GW. Opioid analgesicsand rates of fatal overdose drug poison<strong>in</strong>g<strong>in</strong> the United <strong>State</strong>s. Am J Prev Med.2006;31:506-511.12. Lowe B, 8Unutzer J, Callahan CM, et al.Monitor<strong>in</strong>g depression treatment outcomeswith the patient questionnaire-9. Med Care.2004;42:1194-201.13. Gaynes BN, Deveaugh-Geiss J, Weir S, etal. Feasibility and diagnostic validity of theM-3 checklist: self rated screen fordepressive, bipolar, anxiety and posttraumaticstress disorders <strong>in</strong> primary care.Ann Fam Med. 2010;8:160-169.14. Wilson JF. In the cl<strong>in</strong>ic – low back pa<strong>in</strong>.Ann Intern Med. 2008 ITC5 1-16.15. Chou R, Qaseem A, Snow V, et al.Diagnosis and treatment of low back pa<strong>in</strong>:A jo<strong>in</strong>t cl<strong>in</strong>ical practice quidel<strong>in</strong>e from theAmerican College of Physicians and theAmerican Pa<strong>in</strong> Society. Ann Intern Med.2007;147:478-491.16. O’Conner AB, Dwork<strong>in</strong> RH. Treatment ofneuropathic pa<strong>in</strong>: An overview of recentguidel<strong>in</strong>es. Am J Med. 2009;122:S22-S32.17. Gilron I, Bailey JM, et al. Nortriptyl<strong>in</strong>e andgabapent<strong>in</strong>, alone or <strong>in</strong> comb<strong>in</strong>ation forneuropathic pa<strong>in</strong>: a double-bl<strong>in</strong>d,randomized, placebo controlled crossovertrial. Lancet. 2009;374:1252-1261.18. Dunn KM, Saunders KW. Opioidprescriptions for chronic pa<strong>in</strong> andoverdose: A cohort study. Ann Intern Med.2010;152:85-92.19. Manchikanti L, Cash KA, Damron KS, et al.Controlled substance abuse and illicit druguse <strong>in</strong> chronic pa<strong>in</strong> patients. An evaluationof multiple variables. Pa<strong>in</strong> Physician. 2006;9:215-225.20. 2008 Drug Test<strong>in</strong>g: An overview of MayoCl<strong>in</strong>ic Tests Designed for Detect<strong>in</strong>g Drug<strong>Abuse</strong>. www.Mayo <strong>Medical</strong> Laboratories.com.21. Brown RL, Rounds LA. Conjo<strong>in</strong>t screen<strong>in</strong>gfor alcohol and other drug abuse: criterionvalidity <strong>in</strong> a primary care practice. Wis MedJ. 1995;94:135-140.22. Brown RL, Leonard T, Saunders LA,Papasouliotis O. A two item conjo<strong>in</strong>t screenfor alcohol and other drug problems. Am JFam Pract. 2001;14:95-106.23. Bastiaens L, Riccardi K, Sakhrani D. TheRAFFT as a screen<strong>in</strong>g tool for adultsubstance use disorders. Am J DrugAlcohol <strong>Abuse</strong>. 2002;28:681-691.24. Butler SF, Budman SH, Fernandez K,Jacobson RN. Validation of a screener andopioid assessment measure for patientswith chronic pa<strong>in</strong>. Pa<strong>in</strong>. 2004;112:65-75.25. Webster LR, Webster RM. Predict<strong>in</strong>gaberrant behaviors <strong>in</strong> opioid treatedpatients: prelim<strong>in</strong>ary validation of theOpioid Risk Tool. Pa<strong>in</strong> Med. 2005;6:432-442.26. Passik SD, We<strong>in</strong>reb HJ. Manag<strong>in</strong>g chronicnonmalignant pa<strong>in</strong>: overcom<strong>in</strong>g obstaclesto the use of opioids. Adv Ther.2000;17:70-83.27. Vukimir RB. Drug seek<strong>in</strong>g behavior. Am JDrug Alcohol <strong>Abuse</strong> 2004;30:551-575.MEDICAL EQUIPMENT& SUPPLIESS<strong>in</strong>ce 1858Equipment Leas<strong>in</strong>gAlso Available(New & Used)McLAIN SURGICALSUPPLYA <strong>West</strong> Virg<strong>in</strong>ia Company205 Leon Sullivan WayCharleston, <strong>WV</strong> 25301-2408Phone: 304-343-4384800-729-3195FAX: 304-343-4385CME Post-Test31. Which state has experienced the nation’slargest <strong>in</strong>crease <strong>in</strong> drug overdose mortality?a. Kentuckyb. <strong>West</strong> Virg<strong>in</strong>iac. Louisiana32. Which class of medications may be usefulas an adjunct <strong>in</strong> treat<strong>in</strong>g several formsof chronic pa<strong>in</strong>, <strong>in</strong>clud<strong>in</strong>g neuropathicpa<strong>in</strong>, fibromyalgia, and migra<strong>in</strong>e?a. Opioidsb. Corticosteroidsc. Tricyclic antidepressants33. If pa<strong>in</strong> control is <strong>in</strong>adequate with acetam<strong>in</strong>ophen<strong>in</strong> the elderly patient, which category ofmedications should be considered next?a. NSAIDsb. Opioidsc. Anticonvulsants78 <strong>West</strong> Virg<strong>in</strong>ia <strong>Medical</strong> Journal
Cont<strong>in</strong>u<strong>in</strong>g <strong>Medical</strong> EducationOpportunities at CAMC Health Educationand Research InstituteThe CAMC Health Education and Research Institute is dedicated to improv<strong>in</strong>g health throughresearch, education and community health development. The Institute’s Education Divisionoffers live conferences, sem<strong>in</strong>ars, workshops, teleconferences and on-site programs to healthcare professionals. The CAMC Institute’s CME program is accredited by the AccreditationCouncil for Cont<strong>in</strong>u<strong>in</strong>g <strong>Medical</strong> Education to sponsor cont<strong>in</strong>u<strong>in</strong>g medical education forphysicians. The CAMC Institute designates this educational activity for a maximum of 1 AMAPRA Category 1 Credit(s). Physicians should only claim credit commensurate with theextent of their participation <strong>in</strong> the activity. For more <strong>in</strong>formation on these and future programsprovided by the Institute, please call (304) 388-9960 or fax (304) 388-9966.SEMInARSNo conferences dur<strong>in</strong>g Julyand AugustLIfE SuppORttRAInIngLog-on to our web site toregister at www.camc<strong>in</strong>stitute.orgAdvanced Cardiovascular LifeSupport (ACLS) – ProviderJuly 6, 21; Aug. 10, 16Advanced Cardiovascular LifeSupport (ACLS) – RenewalJuly 8, 23; Aug. 9, 18Advanced Stroke Life SupportJuly 27Basic Life Support (BLS) –Health Care ProviderJuly 6, 20; Aug. 3, 17, 31Pediatric Advanced LifeSupport (PALS) - RenewalJuly 15, 16; Aug. 12, 19Pediatric Advanced LifeSupport (PALS) – ProviderJuly 13; Aug. 25Sepsis SimulationJuly 14; Aug. 4Trauma Nurse Core CourseAug. 23CME OnLInEpROgRAMS/ARCHIvEdguESt LECtuREpROgRAMSLog-on to our web site atwww.camc<strong>in</strong>stitute.orgSystem RequirementsEnvironment: W<strong>in</strong>dows 98, SE,NT, 2000 or XPResolution: 800 x 600Web Browser: Microsoft’sInternet Explorer 5.0 or aboveor Netscape Navigator 4.7x. (Donot use Netscape 7.1)Video Player: W<strong>in</strong>dows MediaPlayer 6.4 or better.Dial-Up or BroadbandConnection. M<strong>in</strong>imumSpeed, 56k (Broadband isRecommended)OtHER ARCHIvEd CMEOppORtunItIES:Geriatric SeriesEthics SeriesResearch SeriesNET Reach library©Charleston Area <strong>Medical</strong> Center Health System, Inc. 201022112-F10